{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:29:57Z","timestamp":1791599397068,"version":"4.3.4"},"reference-count":216,"publisher":"The Endocrine Society","issue":"6","funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Technology Innovation Agency"},{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health Laboratory Services (NHLS) Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1210\/er.2018-00052","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T18:08:01Z","timestamp":1530554881000},"page":"911-937","source":"Crossref","is-referenced-by-count":49,"title":["Gonadotropins and Their Analogs: Current and Potential Clinical Applications"],"prefix":"10.1210","volume":"39","author":[{"given":"Ross C","family":"Anderson","sequence":"first","affiliation":[{"name":"Centre for Neuroendocrinology, University of Pretoria, Pretoria, South Africa"},{"name":"Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L","family":"Newton","sequence":"additional","affiliation":[{"name":"Centre for Neuroendocrinology, University of Pretoria, Pretoria, South Africa"},{"name":"Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Anderson","sequence":"additional","affiliation":[{"name":"MRC Centre for Reproductive Health, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P","family":"Millar","sequence":"additional","affiliation":[{"name":"Centre for Neuroendocrinology, University of Pretoria, Pretoria, South Africa"},{"name":"Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa"},{"name":"Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa"},{"name":"Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa"},{"name":"Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"issue":"6","key":"2019041123345325500_B1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/humrep\/dem046","article-title":"International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum Reprod"},{"issue":"1-2","key":"2019041123345325500_B2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.anireprosci.2005.05.032","article-title":"GnRHs and GnRH receptors","volume":"88","author":"Millar","year":"2005","journal-title":"Anim Reprod Sci"},{"issue":"4","key":"2019041123345325500_B3","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2009-2108","article-title":"Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women","volume":"95","author":"Shaw","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123345325500_B4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ucl.2016.01.001","article-title":"Physiology of the hypothalamic pituitary gonadal axis in the male","volume":"43","author":"Corradi","year":"2016","journal-title":"Urol Clin North Am"},{"issue":"1-2","key":"2019041123345325500_B5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2006.07.007","article-title":"The past, present and future of nongonadal LH\/hCG actions in reproductive biology and medicine","volume":"269","author":"Rao","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2019041123345325500_B6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1095\/biolreprod.114.118562","article-title":"FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice","volume":"91","author":"Stilley","year":"2014","journal-title":"Biol Reprod"},{"issue":"3","key":"2019041123345325500_B7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-2004-831901","article-title":"Regulation of gonadotropins by inhibin and activin","volume":"22","author":"Gregory","year":"2004","journal-title":"Semin Reprod Med"},{"key":"2019041123345325500_B8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2006.04.015","article-title":"Mutations along the pituitary-gonadal axis affecting sexual maturation: novel information from transgenic and knockout mice","volume":"254-255","author":"Huhtaniemi","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"1-2","key":"2019041123345325500_B9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mce.2006.03.026","article-title":"Genetically modified mouse models in studies of luteinising hormone action","volume":"252","author":"Huhtaniemi","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"2019041123345325500_B10","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1210\/en.2016-1104","article-title":"Loss-of-function mutations in the human luteinizing hormone receptor predominantly cause intracellular retention","volume":"157","author":"Newton","year":"2016","journal-title":"Endocrinology"},{"issue":"2","key":"2019041123345325500_B11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng0297-205","article-title":"Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility","volume":"15","author":"Tapanainen","year":"1997","journal-title":"Nat Genet"},{"issue":"1-2","key":"2019041123345325500_B12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0303-7207(98)00179-8","article-title":"Inactivating FSH receptor mutations and gonadal dysfunction","volume":"145","author":"Tapanainen","year":"1998","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2019041123345325500_B13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/eje.0.1380473","article-title":"Mutations of follicle-stimulating hormone and its receptor: effects on gonadal function","volume":"138","author":"Huhtaniemi","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019041123345325500_B14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng0297-201","article-title":"Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility","volume":"15","author":"Kumar","year":"1997","journal-title":"Nat Genet"},{"issue":"2","key":"2019041123345325500_B15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mce.2009.09.003","article-title":"Hormones in synergy: regulation of the pituitary gonadotropin genes","volume":"314","author":"Thackray","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123345325500_B16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mce.2017.03.022","article-title":"Regulation of reproduction via tight control of gonadotropin hormone levels","volume":"463","author":"Coss","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2019041123345325500_B17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/dmu009","article-title":"The kisspeptin-GnRH pathway in human reproductive health and disease","volume":"20","author":"Skorupskaite","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2019041123345325500_B18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fendo.2012.00052","article-title":"Estrogenic regulation of the GnRH neuron","volume":"3","author":"Radovick","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2019041123345325500_B19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1210\/endo-99-1-243","article-title":"Pituitary stalk portal blood collection in rhesus monkeys: evidence for pulsatile release of gonadotropin-releasing hormone (GnRH)","volume":"99","author":"Carmel","year":"1976","journal-title":"Endocrinology"},{"issue":"3","key":"2019041123345325500_B20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3171\/jns.1978.49.3.0382","article-title":"Luteinizing hormone-releasing hormone in human pituitary blood","volume":"49","author":"Antunes","year":"1978","journal-title":"J Neurosurg"},{"issue":"5","key":"2019041123345325500_B21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1210\/endo-111-5-1449","article-title":"Simultaneous measurement of luteinizing hormone-releasing hormone and luteinizing hormone release in unanesthetized, ovariectomized sheep","volume":"111","author":"Levine","year":"1982","journal-title":"Endocrinology"},{"issue":"5","key":"2019041123345325500_B22","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/endo-122-5-2211","article-title":"Simultaneous measurement of luteinizing hormone (LH)-releasing hormone, LH, and follicle-stimulating hormone release in intact and short-term castrate rats","volume":"122","author":"Levine","year":"1988","journal-title":"Endocrinology"},{"issue":"6","key":"2019041123345325500_B23","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/endo-123-6-2946","article-title":"Follicle-stimulating hormone beta subunit messenger ribonucleic acid concentrations during the rat estrous cycle","volume":"123","author":"Ortolano","year":"1988","journal-title":"Endocrinology"},{"issue":"1","key":"2019041123345325500_B24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/endo.138.1.4892","article-title":"Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. I. Direct evidence for separate episodic and basal components of FSH secretion","volume":"138","author":"Padmanabhan","year":"1997","journal-title":"Endocrinology"},{"issue":"2","key":"2019041123345325500_B25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/endo-125-2-917","article-title":"The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression","volume":"125","author":"Dalkin","year":"1989","journal-title":"Endocrinology"},{"issue":"1","key":"2019041123345325500_B26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1210\/endo-128-1-509","article-title":"A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo","volume":"128","author":"Haisenleder","year":"1991","journal-title":"Endocrinology"},{"issue":"1","key":"2019041123345325500_B27","first-page":"3","article-title":"The gene encoding the common alpha subunit of the four human glycoprotein hormones","volume":"1","author":"Fiddes","year":"1981","journal-title":"J Mol Appl Genet"},{"key":"2019041123345325500_B28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fendo.2015.00140","article-title":"Differences in signal activation by LH and hCG are mediated by the LH\/CG receptor\u2019s extracellular hinge region","volume":"6","author":"Grzesik","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6480","key":"2019041123345325500_B29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/369455a0","article-title":"Crystal structure of human chorionic gonadotropin","volume":"369","author":"Lapthorn","year":"1994","journal-title":"Nature"},{"issue":"1","key":"2019041123345325500_B30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.mce.2013.08.021","article-title":"Structural biology of glycoprotein hormones and their receptors: insights to signaling","volume":"382","author":"Jiang","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"2019041123345325500_B31","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1096\/fasebj.2.11.2456242","article-title":"The glycoprotein hormones: recent studies of structure-function relationships","volume":"2","author":"Ryan","year":"1988","journal-title":"FASEB J"},{"issue":"3","key":"2019041123345325500_B32","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1073\/pnas.88.3.760","article-title":"Conversion of human choriogonadotropin into a follitropin by protein engineering","volume":"88","author":"Campbell","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019041123345325500_B33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/endo-126-1-376","article-title":"The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit","volume":"126","author":"Matzuk","year":"1990","journal-title":"Endocrinology"},{"issue":"2","key":"2019041123345325500_B34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/endo.137.2.8593802","article-title":"The role of the asparagine-linked oligosaccharides of the alpha-subunit in human thyrotropin bioactivity","volume":"137","author":"Fares","year":"1996","journal-title":"Endocrinology"},{"issue":"5","key":"2019041123345325500_B35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0021-9258(19)76994-4","article-title":"The role of sialic acid in determining the survival of glycoproteins in the circulation","volume":"246","author":"Morell","year":"1971","journal-title":"J Biol Chem"},{"issue":"3","key":"2019041123345325500_B36","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1210\/jc.2008-2070","article-title":"Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women","volume":"94","author":"Wide","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123345325500_B37","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1210\/endo.131.6.1446593","article-title":"Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides","volume":"131","author":"LaPolt","year":"1992","journal-title":"Endocrinology"},{"issue":"7","key":"2019041123345325500_B38","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/oxfordjournals.humrep.a136208","article-title":"In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP","volume":"10","author":"Lambert","year":"1995","journal-title":"Hum Reprod"},{"issue":"5","key":"2019041123345325500_B39","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/S0021-9258(19)81628-9","article-title":"Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction","volume":"264","author":"Matzuk","year":"1989","journal-title":"J Biol Chem"},{"issue":"7","key":"2019041123345325500_B40","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1074\/jbc.M008093200","article-title":"Engineering a potential antagonist of human thyrotropin and thyroid-stimulating antibody","volume":"276","author":"Fares","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"2019041123345325500_B41","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1210\/en.2005-0012","article-title":"Human thyrotropin (TSH) variants designed by site-directed mutagenesis block TSH activity in vitro and in vivo","volume":"146","author":"Azzam","year":"2005","journal-title":"Endocrinology"},{"issue":"1","key":"2019041123345325500_B42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1095\/biolreprod40.1.48","article-title":"Mutagenesis and gene transfer define site-specific roles of the gonadotropin oligosaccharides","volume":"40","author":"Matzuk","year":"1989","journal-title":"Biol Reprod"},{"issue":"32","key":"2019041123345325500_B43","doi-asserted-by":"crossref","first-page":"17106","DOI":"10.1016\/S0021-9258(18)37504-5","article-title":"Site-specific mutagenesis defines the intracellular role of the asparagine-linked oligosaccharides of chorionic gonadotropin beta subunit","volume":"263","author":"Matzuk","year":"1988","journal-title":"J Biol Chem"},{"issue":"4","key":"2019041123345325500_B44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1083\/jcb.106.4.1049","article-title":"The role of the asparagine-linked oligosaccharides of the alpha subunit in the secretion and assembly of human chorionic gonadotrophin","volume":"106","author":"Matzuk","year":"1988","journal-title":"J Cell Biol"},{"issue":"19","key":"2019041123345325500_B45","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1016\/S0021-9258(17)36748-0","article-title":"Site-directed mutagenesis defines the individual roles of the glycosylation sites on follicle-stimulating hormone","volume":"269","author":"Flack","year":"1994","journal-title":"J Biol Chem"},{"issue":"6","key":"2019041123345325500_B46","first-page":"722","article-title":"Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle stimulating hormone in receptor binding and signal transduction","volume":"8","author":"Bishop","year":"1994","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2019041123345325500_B47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/mend.11.5.9928","article-title":"Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms","volume":"11","author":"Arey","year":"1997","journal-title":"Mol Endocrinol"},{"issue":"3","key":"2019041123345325500_B48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000054310","article-title":"A naturally occurring basically charged human follicle-stimulating hormone (FSH) variant inhibits FSH-induced androgen aromatization and tissue-type plasminogen activator enzyme activity in vitro","volume":"67","author":"Timossi","year":"1998","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2019041123345325500_B49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1677\/joe.0.1650193","article-title":"Differential effects of the charge variants of human follicle-stimulating hormone","volume":"165","author":"Timossi","year":"2000","journal-title":"J Endocrinol"},{"issue":"2","key":"2019041123345325500_B50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1385\/ENDO:10:2:113","article-title":"Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants","volume":"10","author":"Zambrano","year":"1999","journal-title":"Endocrine"},{"issue":"4","key":"2019041123345325500_B51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11154-011-9188-y","article-title":"Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications","volume":"12","author":"Arey","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"2019041123345325500_B52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/molehr\/gax047","article-title":"Heterogeneous hCG and hMG commercial preparations result in different intracellular signalling but induce a similar long-term progesterone response in vitro","volume":"23","author":"Riccetti","year":"2017","journal-title":"Mol Hum Reprod"},{"issue":"4835","key":"2019041123345325500_B53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.3122320","article-title":"Naturally occurring antihormones: secretion of FSH antagonists by women treated with a GnRH analog","volume":"239","author":"Dahl","year":"1988","journal-title":"Science"},{"issue":"2","key":"2019041123345325500_B54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1095\/biolreprod.103.016915","article-title":"Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: studies derived from in vitro and in vivo models","volume":"69","author":"Ulloa-Aguirre","year":"2003","journal-title":"Biol Reprod"},{"issue":"3","key":"2019041123345325500_B55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1210\/me.2009-0347","article-title":"Partially deglycosylated equine LH preferentially activates beta-arrestin-dependent signaling at the follicle-stimulating hormone receptor","volume":"24","author":"Wehbi","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"1","key":"2019041123345325500_B56","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mce.2013.09.035","article-title":"Biased signalling in follicle stimulating hormone action","volume":"382","author":"Landomiel","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123345325500_B57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fendo.2011.00045","article-title":"Mapping the follicle-stimulating hormone-induced signaling networks","volume":"2","author":"Gloaguen","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2019041123345325500_B58","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cellsig.2006.02.011","article-title":"FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A","volume":"18","author":"Hunzicker-Dunn","year":"2006","journal-title":"Cell Signal"},{"issue":"35","key":"2019041123345325500_B59","doi-asserted-by":"crossref","first-page":"21411","DOI":"10.1016\/S0021-9258(18)45750-X","article-title":"Extracellular domain of lutropin\/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity","volume":"265","author":"Xie","year":"1990","journal-title":"J Biol Chem"},{"issue":"7023","key":"2019041123345325500_B60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature03206","article-title":"Structure of human follicle-stimulating hormone in complex with its receptor","volume":"433","author":"Fan","year":"2005","journal-title":"Nature"},{"issue":"3","key":"2019041123345325500_B61","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/ENDO:26:3:179","article-title":"Structural biology of glycoprotein hormones and their receptors","volume":"26","author":"Fan","year":"2005","journal-title":"Endocrine"},{"issue":"31","key":"2019041123345325500_B62","doi-asserted-by":"crossref","first-page":"12491","DOI":"10.1073\/pnas.1206643109","article-title":"Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor","volume":"109","author":"Jiang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019041123345325500_B63","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/me.2013-1115","article-title":"Research resource: novel structural insights bridge gaps in glycoprotein hormone receptor analyses","volume":"27","author":"Kreuchwig","year":"2013","journal-title":"Mol Endocrinol"},{"issue":"12","key":"2019041123345325500_B64","doi-asserted-by":"crossref","first-page":"e52920","DOI":"10.1371\/journal.pone.0052920","article-title":"Extended and structurally supported insights into extracellular hormone binding, signal transduction and organization of the thyrotropin receptor","volume":"7","author":"Krause","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2019041123345325500_B65","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1074\/jbc.M115.701102","article-title":"The activation mechanism of glycoprotein hormone receptors with implications in the cause and therapy of endocrine diseases","volume":"291","author":"Br\u00fcser","year":"2016","journal-title":"J Biol Chem"},{"key":"2019041123345325500_B66","first-page":"834","article-title":"Weitere untersuchungen zur darstellung. biologie und klinik des hypophysenvorderlappenhormons (prolan)","volume":"14","author":"Zondek","year":"1929","journal-title":"Zentralbl Gynakol"},{"issue":"6","key":"2019041123345325500_B67","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmh044","article-title":"Historical perspectives in gonadotrophin therapy","volume":"10","author":"Lunenfeld","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041123345325500_B68","doi-asserted-by":"crossref","unstructured":"Weiss NS , NahuisM, BayramN, MolBW, Van der VeenF, van WelyM. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome. Cochrane Database Syst Rev. 2015;(9):CD010290.","DOI":"10.1002\/14651858.CD010290.pub2"},{"issue":"4","key":"2019041123345325500_B69","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.fertnstert.2008.08.112","article-title":"Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference","volume":"91","author":"Orvieto","year":"2009","journal-title":"Fertil Steril"},{"issue":"10","key":"2019041123345325500_B70","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.89.10.4304","article-title":"Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit","volume":"89","author":"Fares","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019041123345325500_B71","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/humrep\/16.8.1592","article-title":"First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males","volume":"16","author":"Bouloux","year":"2001","journal-title":"Hum Reprod"},{"issue":"8","key":"2019041123345325500_B72","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/humrep\/17.8.1987","article-title":"Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females","volume":"17","author":"Duijkers","year":"2002","journal-title":"Hum Reprod"},{"issue":"6","key":"2019041123345325500_B73","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.92.6.2041","article-title":"Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem","volume":"92","author":"Sugahara","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019041123345325500_B74","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nbt0797-663","article-title":"Design of stable biologically active recombinant lutropin analogs","volume":"15","author":"Garcia-Campayo","year":"1997","journal-title":"Nat Biotechnol"},{"issue":"1-2","key":"2019041123345325500_B75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0303-7207(96)03944-5","article-title":"Expression of biologically active fusion genes encoding the common alpha subunit and either the CG beta or FSH beta subunits: role of a linker sequence","volume":"125","author":"Sugahara","year":"1996","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"2019041123345325500_B76","first-page":"1873","article-title":"Genetic fusion of an alpha-subunit gene to the follicle-stimulating hormone and chorionic gonadotropin-beta subunit genes: production of a bifunctional protein","volume":"13","author":"Kanda","year":"1999","journal-title":"Mol Endocrinol"},{"issue":"2","key":"2019041123345325500_B77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/REP-14-0063","article-title":"Effect of single-chain ovine gonadotropins with dual activity on ovarian function in sheep","volume":"148","author":"Rutigliano","year":"2014","journal-title":"Reproduction"},{"issue":"7","key":"2019041123345325500_B78","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1210\/jc.2002-021201","article-title":"Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone","volume":"88","author":"Perlman","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041123345325500_B79","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/humrep\/deg024","article-title":"Development and characterization of a long-acting recombinant hFSH agonist","volume":"18","author":"Klein","year":"2003","journal-title":"Hum Reprod"},{"issue":"10","key":"2019041123345325500_B80","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1210\/jc.2004-0425","article-title":"Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with o-linked analogs in female rats","volume":"89","author":"Weenen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041123345325500_B81","unstructured":"Low SC, inventor; Bioverativ Therapeutics Inc., assignee. Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility. Patent US7601516B2. 2009."},{"issue":"8","key":"2019041123345325500_B82","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1210\/en.2006-1499","article-title":"Translational fusion of two beta-subunits of human chorionic gonadotropin results in production of a novel antagonist of the hormone","volume":"148","author":"Roy","year":"2007","journal-title":"Endocrinology"},{"issue":"8","key":"2019041123345325500_B83","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1210\/en.2009-0107","article-title":"A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats","volume":"150","author":"Vardhana","year":"2009","journal-title":"Endocrinology"},{"issue":"2","key":"2019041123345325500_B84","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tvjl.2009.02.006","article-title":"Biological and immunological characteristics of porcine follicle-stimulating hormone chemically modified with a polyethylene glycol derivative","volume":"184","author":"Uchiyama","year":"2010","journal-title":"Vet J"},{"issue":"3","key":"2019041123345325500_B85","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0015-0282(02)04804-5","article-title":"First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization","volume":"79","author":"Beckers","year":"2003","journal-title":"Fertil Steril"},{"issue":"1","key":"2019041123345325500_B86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","author":"Corifollitropin alfa Ensure Study Group","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"2019041123345325500_B87","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rbmo.2010.06.032","article-title":"Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF","volume":"21","author":"Fauser","year":"2010","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"2019041123345325500_B88","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.fertnstert.2009.12.070","article-title":"Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial","volume":"94","author":"Fatemi","year":"2010","journal-title":"Fertil Steril"},{"issue":"12","key":"2019041123345325500_B89","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum Reprod"},{"issue":"8","key":"2019041123345325500_B90","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/humrep\/der163","article-title":"Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity","volume":"26","author":"Norman","year":"2011","journal-title":"Hum Reprod"},{"issue":"8","key":"2019041123345325500_B91","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1210\/jc.2010-0360","article-title":"Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency","volume":"95","author":"Roth","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041123345325500_B92","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jc.2008-1648","article-title":"Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome","volume":"94","author":"Liu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019041123345325500_B93","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/andr.262","article-title":"Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study","volume":"2","author":"Rastrelli","year":"2014","journal-title":"Andrology"},{"issue":"1","key":"2019041123345325500_B94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12958-017-0232-y","article-title":"An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism","volume":"15","author":"Nieschlag","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"2019041123345325500_B95","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1210\/jc.2013-2518","article-title":"Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism","volume":"98","author":"Dwyer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041123345325500_B96","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cen.13164","article-title":"Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG\/rFSH treatment outcomes during adolescence","volume":"86","author":"Rohayem","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2019041123345325500_B97","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jcem-18-12-1333","article-title":"Clinical effect of human pituitary follicle-stimulating hormone (FSH)","volume":"18","author":"Gemzell","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041123345325500_B98","first-page":"3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123345325500_B99","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0950-3552(05)80133-6","article-title":"The step-down principle in gonadotrophin treatment and the role of GnRH analogues","volume":"7","author":"Fauser","year":"1993","journal-title":"Baillieres Clin Obstet Gynaecol"},{"issue":"6","key":"2019041123345325500_B100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2019041123345325500_B101","doi-asserted-by":"crossref","first-page":"j138","DOI":"10.1136\/bmj.j138","article-title":"Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis","volume":"356","author":"Wang","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"2019041123345325500_B102","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1038\/s41598-017-03803-9","article-title":"Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis","volume":"7","author":"Yu","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"2019041123345325500_B103","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/humrep\/der401","article-title":"Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study","volume":"27","author":"Homburg","year":"2012","journal-title":"Hum Reprod"},{"issue":"1","key":"2019041123345325500_B104","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/14647270903490765","article-title":"Gonadotrophin ovulation induction is a successful treatment for World Health Organisation Group II anovulatory subfertility in women aged up to 40 and with body mass index up to 34","volume":"13","author":"Li","year":"2010","journal-title":"Hum Fertil (Camb)"},{"issue":"4","key":"2019041123345325500_B105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-M\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"issue":"6","key":"2019041123345325500_B106","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2019041123345325500_B107","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-0034-1375178","article-title":"Best protocol for controlled ovarian hyperstimulation in assisted reproductive technologies: fact or opinion","volume":"32","author":"Polat","year":"2014","journal-title":"Semin Reprod Med"},{"key":"2019041123345325500_B108","first-page":"CD012693","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"9473","key":"2019041123345325500_B109","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(05)66478-1","article-title":"Multiple birth resulting from ovarian stimulation for subfertility treatment","volume":"365","author":"Fauser","year":"2005","journal-title":"Lancet"},{"issue":"23","key":"2019041123345325500_B110","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa1301467","article-title":"Fertility treatments and multiple births in the United States","volume":"369","author":"Kulkarni","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2019041123345325500_B111","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2019041123345325500_B112","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2019041123345325500_B113","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-free clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041123345325500_B114","doi-asserted-by":"crossref","unstructured":"Pandian Z , MarjoribanksJ, OzturkO, SerourG, BhattacharyaS. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev. 2013;(7):CD003416.","DOI":"10.1002\/14651858.CD003416.pub4"},{"issue":"10","key":"2019041123345325500_B115","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/humrep\/14.10.2665","article-title":"Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction\/in-vitro fertilization prior to cancer treatment","volume":"14","author":"Anderson","year":"1999","journal-title":"Hum Reprod"},{"issue":"6","key":"2019041123345325500_B116","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.fertnstert.2013.07.1992","article-title":"Effective method for emergency fertility preservation: random-start controlled ovarian stimulation","volume":"100","author":"Cakmak","year":"2013","journal-title":"Fertil Steril"},{"issue":"19","key":"2019041123345325500_B117","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019041123345325500_B118","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"2019041123345325500_B119","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","article-title":"Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer","volume":"33","author":"Oktay","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019041123345325500_B120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/14647273.2017.1287433","article-title":"Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients","volume":"20","author":"Tsampras","year":"2017","journal-title":"Hum Fertil (Camb)"},{"issue":"6","key":"2019041123345325500_B121","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.rbmo.2017.08.019","article-title":"Double ovarian stimulation during the follicular and luteal phase in women \u226538 years: a retrospective case-control study","volume":"35","author":"Liu","year":"2017","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"2019041123345325500_B122","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil Steril"},{"issue":"32","key":"2019041123345325500_B123","doi-asserted-by":"crossref","first-page":"29871","DOI":"10.1074\/jbc.M104687200","article-title":"The position of the alpha and beta subunits in a single chain variant of human chorionic gonadotropin affects the heterodimeric interaction of the subunits and receptor-binding epitopes","volume":"276","author":"Ben-Menahem","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"2019041123345325500_B124","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1677\/JOE-07-0473","article-title":"Single-chain human gonadotropin analogs induce follicle development in sheep","volume":"196","author":"Lemke","year":"2008","journal-title":"J Endocrinol"},{"issue":"6","key":"2019041123345325500_B125","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0015-0282(02)03113-8","article-title":"Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey","volume":"77","author":"Klein","year":"2002","journal-title":"Fertil Steril"},{"issue":"4","key":"2019041123345325500_B126","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.fertnstert.2004.12.027","article-title":"Effects of long-acting recombinant human follicle-stimulating hormone analogs containing N-linked glycosylation on murine folliculogenesis","volume":"83","author":"Ruman","year":"2005","journal-title":"Fertil Steril"},{"issue":"1","key":"2019041123345325500_B127","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.fertnstert.2007.11.013","article-title":"Efficacy of native and hyperglycosylated follicle-stimulating hormone analogs for promoting fertility in female mice","volume":"91","author":"Trousdale","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"2019041123345325500_B128","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1210\/en.2012-2010","article-title":"Carbohydrate-mediated polyethylene glycol conjugation of TSH improves its pharmacological properties","volume":"154","author":"Park","year":"2013","journal-title":"Endocrinology"},{"key":"2019041123345325500_B129","unstructured":"DeFrees S, Bayer RJ, Bowe C. inventors; Neose Technologies Inc., assignee. Glycopegylated follicle stimulating hormone. Patent US 2008\/0015142 A1. 2008."},{"issue":"6207","key":"2019041123345325500_B130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/337525a0","article-title":"Designing CD4 immunoadhesins for AIDS therapy","volume":"337","author":"Capon","year":"1989","journal-title":"Nature"},{"issue":"4","key":"2019041123345325500_B131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-015-0133-6","article-title":"Fusion proteins for half-life extension of biologics as a strategy to make biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"BioDrugs"},{"issue":"1","key":"2019041123345325500_B132","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tibtech.2014.11.001","article-title":"Fc fusion as a platform technology: potential for modulating immunogenicity","volume":"33","author":"Levin","year":"2015","journal-title":"Trends Biotechnol"},{"key":"2019041123345325500_B133","unstructured":"Russell-Jones GJ, Howe P, de Aizpurua HJ, Burge GL, inventors; Biotech Australia Pty Ltd., assignee. Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof. Patent US5428023A. 1995."},{"issue":"9","key":"2019041123345325500_B134","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/mrd.20672","article-title":"Responsiveness of rabbits to superovulation treatment by a single injection of follicle-stimulating hormone with aluminum hydroxide gel","volume":"74","author":"Hashimoto","year":"2007","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"2019041123345325500_B135","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.theriogenology.2007.02.016","article-title":"Successful superovulation of cattle by a single administration of FSH in aluminum hydroxide gel","volume":"68","author":"Kimura","year":"2007","journal-title":"Theriogenology"},{"issue":"21","key":"2019041123345325500_B136","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1016\/S0021-9258(17)44033-6","article-title":"Deglycosylated human chorionic gonadotropin. An antagonist to desensitization and down-regulation of the gonadotropin receptor-adenylate cyclase system","volume":"258","author":"Rebois","year":"1983","journal-title":"J Biol Chem"},{"issue":"4","key":"2019041123345325500_B137","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbagen.2005.12.022","article-title":"The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists","volume":"1760","author":"Fares","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"2019041123345325500_B138","unstructured":"Moyle WR, inventor; University of Medicine and Dentistry of New Jersey, assignee. Method for making hormone heterodimers. Patent US6486303B1. 2002."},{"issue":"4","key":"2019041123345325500_B139","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0015-0282(16)59829-X","article-title":"The effect of deglycosylated human chorionic gonadotropin on corpora luteal function in healthy women","volume":"49","author":"Patton","year":"1988","journal-title":"Fertil Steril"},{"issue":"13","key":"2019041123345325500_B140","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1021\/bi00282a007","article-title":"Chemically deglycosylated human chorionic gonadotropin subunits: characterization and biological properties","volume":"22","author":"Keutmann","year":"1983","journal-title":"Biochemistry"},{"key":"2019041123345325500_B141","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fendo.2015.00142","article-title":"Discovery and development of small molecule allosteric modulators of glycoprotein hormone receptors","volume":"6","author":"Nataraja","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2019041123345325500_B142","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/2042098614548857","article-title":"Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks","volume":"5","author":"Brynhildsen","year":"2014","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"2019041123345325500_B143","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2012.09.001","article-title":"Emerging opportunities for allosteric modulation of G-protein coupled receptors","volume":"85","author":"Wang","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2019041123345325500_B144","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pharmtox-010716-104710","article-title":"Nanobodies to study G protein-coupled receptor structure and function","volume":"57","author":"Manglik","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"32","key":"2019041123345325500_B145","doi-asserted-by":"crossref","first-page":"19478","DOI":"10.1074\/jbc.R115.662759","article-title":"Novel allosteric modulators of G protein-coupled receptors","volume":"290","author":"Gentry","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041123345325500_B146","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.mce.2012.01.010","article-title":"Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands","volume":"351","author":"Heitman","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"1-3","key":"2019041123345325500_B147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-008-9098-2","article-title":"Allosteric modulators of glycoprotein hormone receptors: discovery and therapeutic potential","volume":"34","author":"Arey","year":"2008","journal-title":"Endocrine"},{"key":"2019041123345325500_B148","first-page":"171","volume-title":"Annual Reports in Medicinal Chemistry","author":"van Straten","year":"2009"},{"key":"2019041123345325500_B149","unstructured":"El Tayer N, Reddy A, Buckler D, Magar S, inventors; Applied Research Systems ARS Holding NV., assignee. FSH mimetics for the treatment of infertility. Patent US6235755B1. 2001."},{"issue":"6","key":"2019041123345325500_B150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0960-894X(96)00097-2","article-title":"The identification of cyclooxygenase-1 inhibitors from 4-thiazolidinone combinatorial libraries","volume":"6","author":"Look","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"2019041123345325500_B151","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0090-9556(25)08418-1","article-title":"Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236)","volume":"24","author":"Mutlib","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"2019041123345325500_B152","first-page":"632","article-title":"Thiazolidinone congeners as central nervous system active agents","volume":"43","author":"Tripathi","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"2019041123345325500_B153","unstructured":"Santora VJ, Covel JA, Hayashi R, Webb RR, inventors; Arena Pharmaceuticals Inc., assignee. Ligands of follicle stimulating hormone receptor and methods of use thereof. Patent WO2005087765A1. 2004."},{"issue":"2","key":"2019041123345325500_B154","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/cc0300154","article-title":"Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library","volume":"6","author":"Maclean","year":"2004","journal-title":"J Comb Chem"},{"issue":"16","key":"2019041123345325500_B155","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1016\/j.bmc.2006.04.012","article-title":"5-Alkylated thiazolidinones as follicle-stimulating hormone (FSH) receptor agonists","volume":"14","author":"Wrobel","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"21","key":"2019041123345325500_B156","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1016\/j.bmc.2005.07.025","article-title":"Preparation of highly substituted gamma-lactam follicle stimulating hormone receptor agonists","volume":"13","author":"Pelletier","year":"2005","journal-title":"Bioorg Med Chem"},{"issue":"19","key":"2019041123345325500_B157","doi-asserted-by":"crossref","first-page":"13226","DOI":"10.1074\/jbc.M600601200","article-title":"Allosteric activation of the follicle-stimulating hormone (FSH) receptor by selective, nonpeptide agonists","volume":"281","author":"Yanofsky","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041123345325500_B158","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bcp.2014.02.023","article-title":"Investigation of a thiazolidinone derivative as an allosteric modulator of follicle stimulating hormone receptor: evidence for its ability to support follicular development and ovulation","volume":"89","author":"Sriraman","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2019041123345325500_B159","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbrc.2008.01.119","article-title":"Differing pharmacological activities of thiazolidinone analogs at the FSH receptor","volume":"368","author":"Arey","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2019041123345325500_B160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2010.12.023","article-title":"A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor","volume":"333","author":"Dias","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"2019041123345325500_B161","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/en.2002-220372","article-title":"Identification and characterization of a selective, nonpeptide follicle-stimulating hormone receptor antagonist","volume":"143","author":"Arey","year":"2002","journal-title":"Endocrinology"},{"issue":"6","key":"2019041123345325500_B162","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/jm049676l","article-title":"Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor","volume":"48","author":"van Straten","year":"2005","journal-title":"J Med Chem"},{"issue":"8","key":"2019041123345325500_B163","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bcp.2013.02.001","article-title":"Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor","volume":"85","author":"van Koppen","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"2019041123345325500_B164","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1021\/jm801561h","article-title":"Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor","volume":"52","author":"Heitman","year":"2009","journal-title":"J Med Chem"},{"issue":"5","key":"2019041123345325500_B165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00210-008-0318-3","article-title":"A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor","volume":"378","author":"van Koppen","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"2019041123345325500_B166","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.bmcl.2006.12.062","article-title":"Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists","volume":"17","author":"Jorand-Lebrun","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"2019041123345325500_B167","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bmcl.2004.01.042","article-title":"Small molecule biaryl FSH receptor agonists. Part 1: Lead discovery via encoded combinatorial synthesis","volume":"14","author":"Guo","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"2019041123345325500_B168","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.bmcl.2004.01.043","article-title":"Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesis","volume":"14","author":"Guo","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"2019041123345325500_B169","unstructured":"Magar S, Goutopoulos A, Liao Y, Schwarz M, Russell TJ, inventors; Applied Research Systems Ars Holding NV., assignee. Piperazine derivatives and methods of use. Patent WO2004031182A1. 2002."},{"key":"2019041123345325500_B170","unstructured":"Timmers CM, Karstens WF, Grima PPM, inventors; NV Organon, assignee. 4-Phenyl-5-oxo-l,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility. Patent WO2006117370A1. 2006."},{"key":"2019041123345325500_B171","unstructured":"Poveda PMG, Karstens WFJ, Timmers CM, inventors; Organon NV, assignee. 4-Phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives for the treatment of infertility. Patent US8022218B2. 2011."},{"issue":"4","key":"2019041123345325500_B172","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.fertnstert.2015.12.017","article-title":"Oral follicle-stimulating hormone agonist tested in healthy young women of reproductive age failed to demonstrate effect on follicular development but affected thyroid function","volume":"105","author":"Gerrits","year":"2016","journal-title":"Fertil Steril"},{"issue":"6","key":"2019041123345325500_B173","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1530\/REP-11-0234","article-title":"Contraception by induction of luteinized unruptured follicles with short-acting low molecular weight FSH receptor agonists in female animal models","volume":"142","author":"van de Lagemaat","year":"2011","journal-title":"Reproduction"},{"issue":"8","key":"2019041123345325500_B174","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.urolonc.2012.03.005","article-title":"The follicle-stimulating hormone receptor: a novel target in genitourinary malignancies","volume":"31","author":"Gartrell","year":"2013","journal-title":"Urol Oncol"},{"issue":"6","key":"2019041123345325500_B175","first-page":"2238","article-title":"Clinical and experimental evidence of inhibition of testosterone production by suramin","volume":"81","author":"Danesi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041123345325500_B176","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-5347(17)37367-6","article-title":"Suramin inhibits gonadotropin action in rat testis: implications for treatment of advanced prostate cancer","volume":"147","author":"Daugherty","year":"1992","journal-title":"J Urol"},{"issue":"2","key":"2019041123345325500_B177","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1385\/ENDO:10:2:153","article-title":"Pharmacological characterization of soluble human FSH receptor extracellular domain: facilitated secretion by coexpression with FSH","volume":"10","author":"Stevis","year":"1999","journal-title":"Endocrine"},{"issue":"2","key":"2019041123345325500_B178","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0026-895X(25)09262-4","article-title":"Inhibition of receptor\/G protein coupling by suramin analogues","volume":"50","author":"Beindl","year":"1996","journal-title":"Mol Pharmacol"},{"issue":"4","key":"2019041123345325500_B179","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0026-895X(25)08769-3","article-title":"Suramin analogues as subtype-selective G protein inhibitors","volume":"49","author":"Freissmuth","year":"1996","journal-title":"Mol Pharmacol"},{"issue":"3","key":"2019041123345325500_B180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0968-0896(01)00324-8","article-title":"Synthesis of (bis)sulfonic acid, (bis)benzamides as follicle-stimulating hormone (FSH) antagonists","volume":"10","author":"Wrobel","year":"2002","journal-title":"Bioorg Med Chem"},{"key":"2019041123345325500_B181","unstructured":"Coats SJ, Fitzpatrick LJ, Hlasta DJ, Lanter CL, Macielag MJ, Pan K, Rivero RA, Palmer SS, inventors; Ortho-McNeil Pharmaceutical Inc., assignee. Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone. Patent US6583179B2. 2003."},{"issue":"1","key":"2019041123345325500_B182","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1095\/biolreprod.113.109397","article-title":"Inhibition of follicle-stimulating hormone-induced preovulatory follicles in rats treated with a nonsteroidal negative allosteric modulator of follicle-stimulating hormone receptor","volume":"90","author":"Dias","year":"2014","journal-title":"Biol Reprod"},{"key":"2019041123345325500_B183","unstructured":"Wortmann L, Cleve A, Muhn HP, Langer G, Schrey A, Kuhne R, Menzenbach B, Koppitz M, Kosemund D, inventors; Bayer Schering Pharma Aktiengesellschaft, assignee. Acyltryptophanols for fertility control. Patent WO2007017289A2. 2005."},{"key":"2019041123345325500_B184","unstructured":"Failli A, Heffernan GD, Santilli AA, Quagliato DA, Coghlan RD, Andrae PM, Croce SC, Shen ES, Trybulski EJ, inventors; Wyeth, assignee. Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists. Patent WO2006135687A1. 2005."},{"issue":"10","key":"2019041123345325500_B185","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/1439-7633(20021004)3:10<1023::AID-CBIC1023>3.0.CO;2-9","article-title":"The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction","volume":"3","author":"van Straten","year":"2002","journal-title":"ChemBioChem"},{"issue":"13","key":"2019041123345325500_B186","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1021\/jm060247s","article-title":"Evaluation of small-molecule modulators of the luteinizing hormone\/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns","volume":"49","author":"Moore","year":"2006","journal-title":"J Med Chem"},{"issue":"15","key":"2019041123345325500_B187","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1074\/jbc.C600014200","article-title":"A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone\/chorionic gonadotropin receptor (LHCGR)","volume":"281","author":"J\u00e4schke","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041123345325500_B188","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1124\/mol.107.039875","article-title":"[3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor","volume":"73","author":"Heitman","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"17","key":"2019041123345325500_B189","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1073\/pnas.1015723108","article-title":"Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist","volume":"108","author":"Newton","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041123345325500_B190","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humrep\/den412","article-title":"Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor","volume":"24","author":"van de Lagemaat","year":"2009","journal-title":"Hum Reprod"},{"issue":"11","key":"2019041123345325500_B191","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1210\/en.2011-1077","article-title":"Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH","volume":"152","author":"van de Lagemaat","year":"2011","journal-title":"Endocrinology"},{"issue":"4","key":"2019041123345325500_B192","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/jc.2012-3404","article-title":"First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive age","volume":"98","author":"Gerrits","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019041123345325500_B193","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/cmdc.200900058","article-title":"Discovery of selective luteinizing hormone receptor agonists using the bivalent ligand method","volume":"4","author":"Bonger","year":"2009","journal-title":"ChemMedChem"},{"issue":"12","key":"2019041123345325500_B194","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/cmdc.200900344","article-title":"Synthesis and pharmacological evaluation of dimeric follicle-stimulating hormone receptor antagonists","volume":"4","author":"Bonger","year":"2009","journal-title":"ChemMedChem"},{"issue":"1","key":"2019041123345325500_B195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/ml100229v","article-title":"Development of selective LH receptor agonists by heterodimerization with a FSH receptor antagonist","volume":"2","author":"Bonger","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"2019041123345325500_B196","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/bcpt.12259_8","article-title":"Fundamental pharmacological mechanisms","volume":"115","author":"Newton","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"2019041123345325500_B197","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1152\/physrev.00037.2010","article-title":"Kisspeptins and reproduction: physiological roles and regulatory mechanisms","volume":"92","author":"Pinilla","year":"2012","journal-title":"Physiol Rev"},{"key":"2019041123345325500_B198","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4614-6199-9_8","article-title":"Kisspeptin antagonists","volume":"784","author":"Roseweir","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"2019041123345325500_B199","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000439337","article-title":"Therapeutic neuroendocrine agonist and antagonist analogs of hypothalamic neuropeptides as modulators of the hypothalamic-pituitary-gonadal axis","volume":"30","author":"Newton","year":"2016","journal-title":"Endocr Dev"},{"issue":"9","key":"2019041123345325500_B200","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1210\/jc.2015-2332","article-title":"Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy","volume":"100","author":"Abbara","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041123345325500_B201","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000336376","article-title":"Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications","volume":"97","author":"Young","year":"2013","journal-title":"Neuroendocrinology"},{"issue":"11","key":"2019041123345325500_B202","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/jc.2016-1202","article-title":"Neurokinin B receptor antagonism in women with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"101","author":"George","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10081","key":"2019041123345325500_B203","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(17)30823-1","article-title":"Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"389","author":"Prague","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2019041123345325500_B204","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/srep08466","article-title":"Neurokinin B administration induces hot flushes in women","volume":"5","author":"Jayasena","year":"2015","journal-title":"Sci Rep"},{"issue":"63","key":"2019041123345325500_B205","doi-asserted-by":"crossref","first-page":"106153","DOI":"10.18632\/oncotarget.22383","article-title":"Treating hot flushes with a neurokinin 3 receptor antagonist","volume":"8","author":"Prague","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"2019041123345325500_B206","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000473893","article-title":"Neurokinin 3 receptor antagonism reveals roles for neurokinin B in the regulation of gonadotropin secretion and hot flashes in postmenopausal women","volume":"106","author":"Skorupskaite","year":"2018","journal-title":"Neuroendocrinology"},{"issue":"36","key":"2019041123345325500_B207","doi-asserted-by":"crossref","first-page":"14574","DOI":"10.1073\/pnas.1212806109","article-title":"Blocking antibody to the \u03b2-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis","volume":"109","author":"Zhu","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7656","key":"2019041123345325500_B208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature22342","article-title":"Blocking FSH induces thermogenic adipose tissue and reduces body fat","volume":"546","author":"Liu","year":"2017","journal-title":"Nature"},{"issue":"3","key":"2019041123345325500_B209","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/JOE-17-0680","article-title":"Actions of pituitary hormones beyond traditional targets","volume":"237","author":"Zaidi","year":"2018","journal-title":"J Endocrinol"},{"issue":"1","key":"2019041123345325500_B210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/en.2017-03118","article-title":"Extragonadal actions of FSH: a critical need for novel genetic models","volume":"159","author":"Kumar","year":"2018","journal-title":"Endocrinology"},{"issue":"3","key":"2019041123345325500_B211","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1385\/ENDO:26:3:317","article-title":"The gonadotropin connection in Alzheimer\u2019s disease","volume":"26","author":"Meethal","year":"2005","journal-title":"Endocrine"},{"issue":"2","key":"2019041123345325500_B212","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1385\/ENDO:29:2:257","article-title":"The role of gonadotropins in Alzheimer\u2019s disease: potential neurodegenerative mechanisms","volume":"29","author":"Barron","year":"2006","journal-title":"Endocrine"},{"issue":"12","key":"2019041123345325500_B213","first-page":"1531","article-title":"Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women","volume":"12","author":"Arslan","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2019041123345325500_B214","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/gyno.1999.5628","article-title":"Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone","volume":"76","author":"Zheng","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2019041123345325500_B215","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0022-5347(06)00273-4","article-title":"Expression and cellular localization of follicle-stimulating hormone receptor in normal human prostate, benign prostatic hyperplasia and prostate cancer","volume":"175","author":"Mariani","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"2019041123345325500_B216","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2006-0036","article-title":"Gonadotropins and ovarian cancer","volume":"28","author":"Choi","year":"2007","journal-title":"Endocr Rev"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/39\/6\/911\/26555153\/er.2018-00052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T14:17:07Z","timestamp":1751725027000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/39\/6\/911\/5047286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":216,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,7,2]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2018-00052","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,7,2]]}}}